✦ LIBER ✦

Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study

✍ Scribed by Fleming, Gini F.; Filiaci, Virginia L.; Marzullo, Brandon; Zaino, Richard J.; Davidson, Susan A.; Pearl, Michael; Makker, Vicky; Burke, James J.; Zweizig, Susan L.; Van Le, Linda; Hanjani, Parviz; Downey, Gordon; Walker, Joan L.; Reyes, Henry D.; Leslie, Kimberly K.

Book ID: 121834240
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 879 KB
Volume: 132
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2014.01.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of alternating courses of

Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

✍ James V Fiorica; Virginia L Brunetto; Parviz Hanjani; Samuel S Lentz; Robert Man 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Treatment of advanced or recurrent endom

Treatment of advanced or recurrent endometrial carcinoma with medroxyprogesterone acetate (MPA): A gynecologic oncology group study

✍ T. Thigpen; J. Blessing; P. DiSaia; C. Ehrlich 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Phase II trial of combination bevacizuma

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study

✍ E. Alvarez; W. Brady; J. Walker; J. Rotmensch; X. Zhou; J. Kendrick; S. Yamada; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Phase II trial of combination bevacizuma

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study

✍ Alvarez, Edwin A.; Brady, William E.; Walker, Joan L.; Rotmensch, Jacob; Zhou, X 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Phase III Trial of Doxorubicin Plus Cisp

Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

✍ Fleming, G. F. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 194 KB

A randomized trial of megestrol acetate

A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer: A study of the Eastern Cooperative Oncology Group (E2185)

✍ Charles D. Cobau; Katrien Declercq; Donna Neuberg; James N. Ingle; Douglass C. T 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

## BACKGROUND. Human breast cancer cells in vitro exhibit increased levels of progestin receptors (PgR) after brief exposure to physiologic concentrations of estrogens. Prior clinical studies have positively correlated the responsiveness of metastatic breast cancer to progestin therapy with the le